Navigation Links
BibsToGo.com Answers: How Can a Traditional Baby Product Help Corporate America Look Better?
Date:11/4/2009

Using clever web videos, BibsToGo.com launches a line of disposable, recyclable and customizable bibs to help keep both children and adults looking clean and stain free. The videos were produced and distributed by Intelligent Video Solutions of Rye, NY.


Dix Hills, NY (PRWEB) November 4, 2009 -- Andre Muller is a successful entrepreneur who has spent the last 20 years in sales and distribution within the video gaming industry. Necessity is the mother of invention and BibsToGo.com was born out of one too many stains on Andre’s suit, shirt or tie before an important sales meeting or presentation.

BibsToGo are oversized, absorbent, waterproof, disposable and recyclable bibs that slip over the head and rip off easily. Napkins did not adequately cover Andre, and like most professionals, he found himself spending up to $1,000 a year on dry cleaning bills to remove stains. There are over 300,000 fast food restaurants in the US and eating and drinking while traveling is increasing. Multi-tasking can lead to making a mess of one’s self. BibsToGo.com wants to help people show up neat, as first impressions mean more now than ever before.

BibsToGo.com can print company logos on their products and they can create custom packaging for their clients. Andre says “The material is very futuristic. In a July 2009 article on QSRMagazine.com, one writer said a future trend in the restaurant industry will be workers wearing uniforms made of our fabric for their shifts and then throwing them out – rather than having the expense of washing and drying uniforms.”

BibsToGo.com hired Intelligent Video Solutions to produce a professional B2C YouTube video, as well as a B2B Corporate Video, to help Andre and his sales reps get their product out in an entertaining and consistent way. “IVS came up with the concepts, scripted the videos, shot, edited and uploaded
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2

Related medicine news :

1. Joint Center to Unveil Health Reform Study Providing Answers: What Is the Cost of Not Addressing Racial Health Disparities?
2. Success Targeting Competencies Missed in Traditional Testing Leads to Selection of Amistaff for Poster Presentations on Prophecy's Video-Based Situational Assessments
3. College Clinic Offers Traditional Chinese Medical Services to Public
4. faces Launches Facial Contouring AccuLiftTM Procedure ... New Laser Procedure From Lutronic Gives Traditional Face Lift A Makeover
5. California Surgeon (laserbacksurgery.com) Pioneers Exciting Alternative to Traditional Spinal Stenosis Treatment
6. Traditional Chinese Medicine and Acupuncture Continue to Grow in Popularity Due to Focus on Natural Health
7. Japanese Fine Tailoring Revolutionizes Traditional Doctor Coats
8. Paul Capital Healthcare to Participate in Panel on Non-Traditional Forms of Financing
9. Common Sense Pediatrics: Combining Alternative and Traditional Medicine in Everyday Practice
10. In Time for Better Hearing and Speech Month: VidaCura.com and Nexear Offers Consumers an Alternative to Traditional Costly Hearing Aids
11. Women More Likely to Experience Non-Traditional Stroke Symptoms
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
BibsToGo.com Answers: How Can a Traditional Baby Product Help Corporate America Look Better?   
BibsToGo.com Answers: How Can a Traditional Baby Product Help Corporate America Look Better?
Breaking Medicine Technology:Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6Dynatronics Receives 180-Day NASDAQ Extension 2Nearly 100 HIV/AIDS Drugs and Vaccines in Development Pipeline 2YAI NIPD Board of Trustees Elects Eliot Green Chair and Sheldon Kwiat Vice Chair 51695 1YAI NIPD Board of Trustees Elects Eliot Green Chair and Sheldon Kwiat Vice Chair 51695 2YAI NIPD Board of Trustees Elects Eliot Green Chair and Sheldon Kwiat Vice Chair 51695 3OH2 Medical Spa Achieves the First U S LEED 28R 29 Certification for a Medical Commercial Interior 51691 1OH2 Medical Spa Achieves the First U S LEED 28R 29 Certification for a Medical Commercial Interior 51691 2Fitness Might Limit Strokes Impact 51687 1Fitness Might Limit Strokes Impact 51687 2